Lisinopril (Page 8 of 8)

PRINCIPAL DISPLAY PANEL – 5 mg

NDC 51079-981-20

Lisinopril
Tablets, USP
5 mg

100 Tablets (10 x 10)

Each tablet contains:
Lisinopril, USP 5 mg

Usual Dosage: See accompanying
prescribing information.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from moisture, freezing
and excessive heat.

Code No.: MH/DRUGS/AD/089

Manufactured for:
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Made in India

Rx only

S-11931

Packaged and Distributed by:

Mylan Institutional Inc.

Rockford, IL 61103 U.S.A.

This unit dose package is not child resistant.

For institutional use only.

Keep this and all drugs out of the reach of children.

This container provides light-resistance.

See window for lot number and expiration date.

Lisinopril 5 mg Tablets Unit Carton Label
(click image for full-size original)
Unit Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL – 10 mg

NDC 51079-982-20

Lisinopril
Tablets, USP
10 mg

100 Tablets (10 x 10)

Each tablet contains:
Lisinopril, USP 10 mg

Usual Dosage: See accompanying
prescribing information.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from moisture, freezing
and excessive heat.

Code No.: MH/DRUGS/AD/089

Manufactured for:
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Made in India

Rx only

S-11933

Packaged and Distributed by:

Mylan Institutional Inc.

Rockford, IL 61103 U.S.A.

This unit dose package is not child resistant.

For institutional use only.

Keep this and all drugs out of the reach of children.

This container provides light-resistance.

See window for lot number and expiration date.

Lisinopril 10 mg Tablets Unit Carton Label
(click image for full-size original)
Unit Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL – 20 mg

NDC 51079-983-20

Lisinopril
Tablets, USP
20 mg

100 Tablets (10 x 10)

Each tablet contains:
Lisinopril, USP 20 mg

Usual Dosage: See accompanying
prescribing information.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from moisture, freezing
and excessive heat.

Code No.: MH/DRUGS/AD/089

Manufactured for:
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Made in India

Rx only

S-11935

Packaged and Distributed by:

Mylan Institutional Inc.

Rockford, IL 61103 U.S.A.

This unit dose package is not child resistant.

For institutional use only.

Keep this and all drugs out of the reach of children.

This container provides light-resistance.

See window for lot number and expiration date.

Lisinopril 20 mg Tablets Unit Carton Label
(click image for full-size original)
Unit Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL – 40 mg

NDC 51079-984-20

Lisinopril
Tablets, USP
40 mg

100 Tablets (10 x 10)

Each tablet contains:
Lisinopril, USP 40 mg

Usual Dosage: See accompanying
prescribing information.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from moisture, freezing
and excessive heat.

Code No.: MH/DRUGS/AD/089

Manufactured for:
Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Made in India

Rx only

S-11937

Packaged and Distributed by:

Mylan Institutional Inc.

Rockford, IL 61103 U.S.A.

This unit dose package is not child resistant.

For institutional use only.

Keep this and all drugs out of the reach of children.

This container provides light-resistance.

See window for lot number and expiration date.

Lisinopril 40 mg Tablets Unit Carton Label
(click image for full-size original)
Unit Carton
(click image for full-size original)
LISINOPRIL lisinopril tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51079-981(NDC:0378-2073)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LISINOPRIL (LISINOPRIL ANHYDROUS) LISINOPRIL 5 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
MAGNESIUM STEARATE
MANNITOL
POVIDONE, UNSPECIFIED
STARCH, CORN
SODIUM LAURYL SULFATE
FD&C YELLOW NO. 6
Product Characteristics
Color orange (peach) Score 2 pieces
Shape ROUND Size 8mm
Flavor Imprint Code M;L23
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:51079-981-20 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (51079-981-01)
1 NDC:51079-981-01 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (51079-981-20)
2 NDC:51079-981-56 10 DOSE PACK in 1 CARTON contains a DOSE PACK (51079-981-30)
2 NDC:51079-981-30 30 BLISTER PACK in 1 DOSE PACK This package is contained within the CARTON (51079-981-56) and contains a BLISTER PACK (51079-981-01)
2 NDC:51079-981-01 1 TABLET in 1 BLISTER PACK This package is contained within a DOSE PACK (51079-981-30) and a CARTON (51079-981-56)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076071 08/01/2002
LISINOPRIL lisinopril tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51079-982(NDC:0378-2074)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LISINOPRIL (LISINOPRIL ANHYDROUS) LISINOPRIL 10 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
MAGNESIUM STEARATE
MANNITOL
POVIDONE, UNSPECIFIED
STARCH, CORN
SODIUM LAURYL SULFATE
Product Characteristics
Color white Score no score
Shape ROUND Size 8mm
Flavor Imprint Code L;24;M
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:51079-982-20 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (51079-982-01)
1 NDC:51079-982-01 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (51079-982-20)
2 NDC:51079-982-19 25 BLISTER PACK in 1 CARTON contains a BLISTER PACK (51079-982-17)
2 NDC:51079-982-17 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (51079-982-19)
3 NDC:51079-982-56 10 DOSE PACK in 1 CARTON contains a DOSE PACK (51079-982-30)
3 NDC:51079-982-30 30 BLISTER PACK in 1 DOSE PACK This package is contained within the CARTON (51079-982-56) and contains a BLISTER PACK (51079-982-01)
3 NDC:51079-982-01 1 TABLET in 1 BLISTER PACK This package is contained within a DOSE PACK (51079-982-30) and a CARTON (51079-982-56)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076071 08/01/2002
LISINOPRIL lisinopril tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51079-983(NDC:0378-2075)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LISINOPRIL (LISINOPRIL ANHYDROUS) LISINOPRIL 20 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
MAGNESIUM STEARATE
MANNITOL
POVIDONE, UNSPECIFIED
STARCH, CORN
SODIUM LAURYL SULFATE
D&C YELLOW NO. 10
Product Characteristics
Color yellow Score no score
Shape ROUND Size 8mm
Flavor Imprint Code L;25;M
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:51079-983-20 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (51079-983-01)
1 NDC:51079-983-01 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (51079-983-20)
2 NDC:51079-983-19 25 BLISTER PACK in 1 CARTON contains a BLISTER PACK (51079-983-17)
2 NDC:51079-983-17 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (51079-983-19)
3 NDC:51079-983-56 10 DOSE PACK in 1 CARTON contains a DOSE PACK (51079-983-30)
3 NDC:51079-983-30 30 BLISTER PACK in 1 DOSE PACK This package is contained within the CARTON (51079-983-56) and contains a BLISTER PACK (51079-983-01)
3 NDC:51079-983-01 1 TABLET in 1 BLISTER PACK This package is contained within a DOSE PACK (51079-983-30) and a CARTON (51079-983-56)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076071 08/01/2002
LISINOPRIL lisinopril tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51079-984(NDC:0378-2076)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LISINOPRIL (LISINOPRIL ANHYDROUS) LISINOPRIL 40 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
MAGNESIUM STEARATE
MANNITOL
POVIDONE, UNSPECIFIED
STARCH, CORN
SODIUM LAURYL SULFATE
FD&C BLUE NO. 2
D&C YELLOW NO. 10
Product Characteristics
Color green Score no score
Shape ROUND Size 8mm
Flavor Imprint Code L;26;M
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:51079-984-20 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (51079-984-01)
1 NDC:51079-984-01 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (51079-984-20)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076071 08/01/2002
Labeler — Mylan Institutional Inc. (039615992)
Registrant — Mylan Institutional Inc. (039615992)
Establishment
Name Address ID/FEI Operations
Mylan Institutional Inc. 039615992 relabel (51079-983), relabel (51079-984), repack (51079-981), repack (51079-982), repack (51079-983), repack (51079-984), relabel (51079-981), relabel (51079-982)
Establishment
Name Address ID/FEI Operations
Mylan Pharmaceuticals Inc. 059295980 analysis (51079-981), analysis (51079-982), analysis (51079-983), analysis (51079-984), manufacture (51079-981), manufacture (51079-982), manufacture (51079-983), manufacture (51079-984)

Revised: 03/2018 Mylan Institutional Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.